U.S. Markets closed

UCB SA (UCBJY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
35.350.00 (0.00%)
At close: 3:03PM EDT
People also watch
TKPYYMKGAYUMICYDSNKYESALY
Full screen
Previous Close35.35
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume15
Avg. Volume1,993
Market Cap12.79B
Beta0.32
PE Ratio (TTM)22.41
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.63 (1.78%)
Ex-Dividend Date2017-04-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com2 months ago

    UCB Stock Plunges After Trials Reveal Safety Risk in Amgen JV

    UCB stock plummeted Monday after clinical trials shone a light over a possible safety risk related to the Osteoporosis treatment that it has been developing alongside Amgen

  • UCB SA : UCBJY-US: Dividend Analysis : May 02nd, 2017 (record date) : By the numbers : April 28, 2017
    Capital Cube3 months ago

    UCB SA : UCBJY-US: Dividend Analysis : May 02nd, 2017 (record date) : By the numbers : April 28, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing UCB SA with the following peers – Amgen Inc., Shire PLC Sponsored ADR, Pfizer Inc., Biogen Inc., Novartis AG Sponsored ADR and Catalyst Pharmaceuticals, Inc. (AMGN-US, SHPG-US, PFE-US, BIIB-US, NVS-US and CPRX-US). UCB SA’s dividend yield is 1.03 percent and its dividend payout is 24.00 ... Read more (Read more...)

  • UCB SA :UCBJY-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017
    Capital Cube5 months ago

    UCB SA :UCBJY-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017

    Categories: Yahoo Finance Get free summary analysis UCB SA reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of UCB SA – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US and NVS-US) that have also reported for ... Read more (Read more...)